EUDR: Parliament objects to risk classification
The European Parliament on Wednesday raised an objection to the EU Deforestation Regulation's (EUDR) risk list. However, the Parliament's decision is not legally binding.
By Amélie Günther
The European Parliament on Wednesday raised an objection to the EU Deforestation Regulation's (EUDR) risk list. However, the Parliament's decision is not legally binding.
By Amélie Günther
The European Commission wants to encourage member states to stockpile a broad range of strategic reserves. In light of growing geopolitical threats, more coordination is also necessary, said Commissioner Hadja Lahbib.
By Stephan Israel
With 136 Members of the European Parliament, the Socialists & Democrats (S&D) are the second-largest force in the informal Von der Leyen coalition. Yet translating that numerical strength into political influence remains an uphill struggle.
By Markus Grabitz
Initial reactions to the leaked Commission draft for the European Competitiveness Fund (ECF) are critical, particularly concerning a perceived expansion of Commission powers and a weakening of the European Parliament’s role.
By János Allenbach-Ammann
Business associations miss the fact that the new delegated act for low-carbon hydrogen does not allow PPAs with renewable energy plants to be taken into account. The NGO CAN Europe, on the other hand, sees a permanent loophole for LNG in the legislation.
By Manuel Berkel
In consumer policy, the European Commission must close regulatory gaps and account for major shifts like climate change and digitalization, argues Isabelle Buscke of the Federation of German Consumer Organizations. Consumer interests are not an obstacle to growth – they are its foundation.
By Isabelle Buscke
China’s Ministry of Foreign Affairs has denied claims that a Chinese warship targeted a German military aircraft with a laser in the Red Sea. According to a ministry spokesperson, the German Foreign Office’s account "contradicts the facts known to the Chinese side".
By Leonardo Pape
China’s producer prices have dropped to their lowest level in nearly two years. The decline reflects an intensifying price war within the Chinese economy.
By Leonardo Pape